Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...

Mitsubishi Tanabe Pharma, for over 500 billion yen . This move aligns with Mitsubishi Chemical's strategy to streamline its operations and concentrate on core sectors such as vehicle ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

The deal values Mitsubishi Tanabe Pharma at about 510 billion yen (S$4.53 billion), according to a statement on Friday (Feb 7), which confirmed an earlier report from Bloomberg News. The transaction ...